Table 2.
Features of ten publicly available microarray data sets used to validate published risk scores
| Data sets | Microarray platform | Sample size (n) | Information about ER | Information about LN |
|---|---|---|---|---|
| ETABM158 | U133A | 130 | Yes | Yes |
| GSE11121 | U133A | 200 | Yes | Yes |
| GSE2034 | U133A | 286 | Yes | Yes |
| GSE25066 | U133A | 508 | Yes | Yes |
| GSE2603 | U133A | 121 | Yes | Yes |
| GSE3494-GPL96 | U133A | 251 | Yes | Yes |
| GSE45255 | U133A | 139 | Yes | Yes |
| GSE4922-GPL96 | U133A | 289 | Yes | Yes |
| GSE6532-GPL96 | U133A | 327 | Yes | Yes |
| GSE7390 | U133A | 198 | Yes | Yes |
| Total | 2,449 | 10 | 10 |
Abbreviations: ER, estrogen receptor; LN, lymph node.